Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer | |
Liu, Zheng; Zhu, Yu; Xu, Le; Zhang, Junyu; Xie, Huyang; Fu, Hangcheng; Zhou, Quan; Chang, Yuan; Dai, Bo; Xu, Jiejie | |
刊名 | ONCOIMMUNOLOGY |
2018 | |
卷号 | 7期号:9 |
关键词 | adjuvant chemotherapy bladder cancer mast cells overall survival prognosis recurrence-free survival |
ISSN号 | 2162-402X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3606162 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Liu, Zheng,Zhu, Yu,Xu, Le,et al. Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer[J]. ONCOIMMUNOLOGY,2018,7(9). |
APA | Liu, Zheng.,Zhu, Yu.,Xu, Le.,Zhang, Junyu.,Xie, Huyang.,...&Xu, Jiejie.(2018).Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer.ONCOIMMUNOLOGY,7(9). |
MLA | Liu, Zheng,et al."Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer".ONCOIMMUNOLOGY 7.9(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论